Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
One Six 8 Ventures is an operator-led venture capital fund founded with the mission to partner with entrepreneurs in the MedTech sector. Established in Canada, the firm focuses on addressing critical health inefficiencies through strategic investments and guidance. The firm aims to scale next-generation MedTech solutions globally, particularly in underfunded regions like Canada. With a commitment to fostering innovation, One Six 8 Ventures emphasizes collaboration with founders to navigate the complexities of the healthcare landscape. The firm is dedicated to investing in early-stage companies that demonstrate technical excellence and substantial market opportunities, ensuring that they are well-positioned to make a significant impact in the healthcare sector.
One Six 8 Ventures specializes in early-stage investments within the MedTech sector, with a particular emphasis on high-growth areas such as AI-MedTech, surgical tools and robotics, and remote patient monitoring. The firm actively seeks out companies that are developing innovative solutions to address pressing healthcare challenges. By targeting underfunded regions, especially in Canada, One Six 8 Ventures aims to uncover unique investment opportunities that may be overlooked by other investors. The fund's investment strategy is rooted in a deep understanding of the healthcare market, allowing them to identify and support companies that are poised for growth and can deliver impactful solutions to improve patient care.
One Six 8 Ventures boasts a portfolio of notable companies that are at the forefront of MedTech innovation. Among these is **Fluid Biomed**, which is developing a hybrid polymer-metal flow-diverting stent designed to cure brain aneurysms. This innovative product features a unique construction that enhances vessel healing and improves post-operative visualization. Another key investment is **PulseMedica**, which is creating a non-invasive, image-guided laser platform for treating eye floaters and other vitreoretinal diseases. This platform integrates advanced laser technology with machine learning to provide automated care. Additionally, **Respiree** offers an end-to-end cardio-pulmonary platform for remote care, utilizing wearable sensors and AI for real-time clinical monitoring and chronic disease management. These companies exemplify One Six 8 Ventures' commitment to supporting groundbreaking technologies that address critical health issues.
One Six 8 Ventures invests in early-stage companies, specifically at the pre-seed, seed, and seed-plus stages. This focus allows them to partner closely with entrepreneurs from the outset, providing the necessary support and resources to help scale their innovations.
The firm primarily focuses on the MedTech sector, with particular interest in areas such as AI-MedTech, surgical tools and robotics, and remote patient monitoring. This specialization enables them to identify and invest in companies that are developing transformative healthcare solutions.
One Six 8 Ventures is based in Canada and primarily invests in North America. They have a strong emphasis on targeting underfunded regions, particularly within Canada, to uncover unique investment opportunities that align with their mission.
While specific check sizes are not detailed in the source material, One Six 8 Ventures focuses on early-stage investments, which typically range from pre-seed to seed funding levels. This suggests that their investments are likely tailored to the needs of early-stage MedTech companies.
The source material does not provide specific details about the application process for One Six 8 Ventures. However, it is advisable for founders to reach out directly to the firm for guidance on how to pitch their ideas and the preferred format for submissions.
While specific support mechanisms are not outlined in the source material, One Six 8 Ventures emphasizes its operator-led approach, suggesting that they provide strategic guidance and mentorship to their portfolio companies to help them navigate the complexities of the MedTech landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.